Today’s stock pick update – Open Now

[Learn More]( [REQUIRED by Law to Pay Out When You Request It]( If You've Got Some Free Time Today... Find out why Barron’s calls it “one of the greatest strategies in existence.” Twenty-year trading veteran teaches you how to make as much as $2,690 per week with this low-risk strategy you can use at home.(Ad) [Free details here.]( Pfizer Shares Climb After Positive Data On Its Coronavirus Vaccine [Pfizer]( shares are up 4.5% this morning and [BioNTech]( is up nearly 6% after Pfizer released positive results from its early-stage human trial of the pair’s coronavirus vaccine. The trial showed that one of the vaccine candidates produced neutralizing antibodies for the deadly virus, and after 28 days, all participants in two of the dose g... [Read More]( Alterity Therapeutics (NASDAQ: [ATHE]( Alterity shares are up nearly 54% as of this writing following yesterday’s announcement that it has received guidance from the FDA on the development pathway for ATH434, the company’s lead compound for the treatment of Multiple System Atrophy (MSA), a Parkinsonian disorder. “The FDA clearly recognizes the seriousness of MSA and the need f... [Read More]( [Is the time right to buy VZ’s discount?]( Increasing fear is something that tends to drive average investors away from the markets; but for those who can take a longer-term view, including the ability the take a contrarian perspective of things, can usually find terrific opportunities in those kinds of conditions. An example of what I mean is to look at the reality that coronavirus-driven fear forced the closure or retail businesses all around the world for a big portion of the second quarter of the year, and that even as many of tho... [Read More]( Featured Stock [Co-Diagnostics, Inc. (CODX) – Buy Price: $19.75 or better]( Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was founded in 2013 and is headquartered in Salt Lake City, Utah. [Read More]( Other Top Stories - [Fed minutes show concerns about severity of downturn]( - [US transfers care for towns polluted with asbestos to state]( - [Minutes for Fed's June meeting show officials concerned about severity of economic damage from virus-induced downturn]( - [5 things to watch for in Thursday's jobs report for June]( - [Treasury to loan $700M to trucking company DOD sued in 2018]( Trend Following Picks - [Co-Diagnostics, Inc. (CODX) – Buy Price: $19.75 or better]( - [Paramount Gold Nevada Corp. (PZG) – Buy Price: $1.35 or better]( - [Chegg, Inc. (CHGG) – Buy Price: $70 or better]( - [Natera, Inc. (NTRA) – Buy Price: $47.50 or better]( - [Genprex, Inc. (GNPX) – Buy Price: $4.00 or better]( [All Picks]( Reversal Picks - [Just Energy Group Inc. (JE) Buy Target $0.64 Sell Target $0.74]( - [Baytex Energy Corp. (BTE) Buy Target $0.56 Sell Target $0.63]( - [Precision Drilling Corporation (PDS) Buy Target $0.81 Sell Target $0.88]( - [Amyris, Inc. (AMRS) – Buy Price: $4.24 -Sell Price: $5.16]( - [Arvinas, Inc. (ARVN) Buy Target $36.90 Sell Target $45.42]( [All Picks]( Low Price Stock Picks - [CVR Partners, LP (UAN)]( - [Western Copper and Gold Corporation (WRN)]( - [Ocwen Financial Corporation (OCN)]( - [Alexco Resource Corp. (AXU)]( - [Citius Pharmaceuticals, Inc. (CTXR)]( [All Picks]( Already subscribed to our premium service? [Click here to Login.]( Not a TradersPro subscriber yet? [Learn More About TradersPro Here - Learn The # 1 Key To Successful Stock Investing Profits]( --------------------------------------------------------------- This email was sent to {EMAIL} by Investiv, LLC 265 N. Main | Ste. D #283 | Kaysville | UT | 84037 [Forward to a friend]( | [Unsubscribe]( or [Mange which emails you get from TradersPro]( Disclaimers Investing is Inherently Risky There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses. Hypothetical Results Are Reported Results and examples used in the Company’s advertisements, books, videos, websites, and other media—including on the Site and the Network—are, in some cases, based on hypothetical (simulated) trades. Plainly speaking, these trades were not actually executed. Hypothetical performance results have certain limitations. Unlike an actual performance record, hypothetical results do not represent actual trading. Also, since the trades have not been executed, the hypothetical results may have under-or-over compensation for the impact, if any, of certain market factors, such as lack of liquidity. Hypothetical trading programs generally are also subject to the fact that they are designed with the benefit of hindsight. Hypothetical results also do not account for commissions or slippage. The Company’s simulations assume purchase and sale prices believed to be attainable. Yet traders are going to be getting into trades at different times and using various exit approaches, which may result in different pricing and outcomes. You may or may not receive the best available price on the purchase or the sale of a position in actual trading. Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Company’s software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified. Offers Disinterested Commentary and Analysis The Company does not receive any form of payment or other compensation for publishing information, news, research, or any other material concerning specific securities on the Network that is intended to affect or influence the value of securities. The Company, and its personnel, do not engage in front-running of recommendations and do not trade against one’s own recommendations. The Company and its management may benefit from an increase or decrease in the share prices of the profiled companies, and/or may have other actual or potential conflicts of interest. If a particular security featured in a newsletter publication is concurrently owned by the Company in its corporate brokerage account, or in any of the individual accounts of the Company’s principals or analysts / writers, that fact will be disclosed. The Company, its principals, analysts and writers may choose to purchase a security or derivative featured in one of its newsletter publications, but typically will wait three (3) trading days from the date of publication before initiating said purchase. [Disclaimers, Terms & Conditions]( | [Privacy Policy]( Copyright © 2019